p-Hydroxyphenylacetic acid
|
Basic information |
| Metabolite name | p-Hydroxyphenylacetic acid |
 | HMDB0000020 |
 |
C00642 |
 |
127 |
| Synonyms | 4-hydroxyphenylacetate; |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | p-Hydroxyphenylacetic acid |
| HMDB0000020 |
|
C00642 |
|
127 |
| Synonyms | 4-hydroxyphenylacetate; |
| No. of studies | 8 |
|
Relationship between p-Hydroxyphenylacetic acid and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M036 | Type1 | MDD group vs. control group | Urine | Human | Down |
| Study M037 | Type2 | sertraline treatment group four-week vs. baseline | Serum | Human | Up |
| Study M052 | Type1 | HIV-positive and HIV-negative cohorts depressed vs. controls | Plasma | Human | Down |
| Study M058 | Type1 | depressed HBV-infected patients group vs. control group and non-depressed HBV-infected group | Urine | Human | Down |
| Study M102 | Type1 | severe MDD group vs. control group | Urine | Human | Up |
| Study M531 | Type2 | MDD with escitalopram/citalopram treatment, 8-week vs. baseline | Plasma | Human | Up |
| Study M615 | Type1 | high-fat diet group vs. control group | Faece | C57BL/6J mouse | Down |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |